Missing Not News Today

Additional data demonstrates positive results of pridopidine drug on Total Functional Capacity Positive results from additional analyses of PRIDE-HD and Open-HART trials with pridopidine published in a peer-reviewed journal, The Journal of Huntingtons Disease. Exploratory additional efficacy data show pridopidine (45 mg bid) to be the first drug to exert a significant and clinically meaningful beneficial effect on Total Functional Capacity (TFC). Results from the Open-HART trial demonstrate the...

 E-Mail Positive results from additional analyses of PRIDE-HD and Open-HART trials with pridopidine published in peer-reviewed journal, The Journal of Huntingtons Disease. Exploratory additional efficacy data show pridopidine (45 mg bid) to be the first drug to exert a significant and clinically meaningful beneficial effect on Total Functional Capacity (TFC). Results from Open-HART trial demonstrate potential durability of the effect of pridopidine with less TFC decline over 5 years compare...